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Abstract

Cardiovascular disease (CVD) claims more lives than any other disease in the
world. Although numerous biological pathways share the blame, ventricular
tachyarrhythmia (VT) is estimated to account for ~25% of all CVD deaths. A
complete understanding of the molecular mechanisms underlying VT is unknown
but recent studies have linked VT to improper calcium handling in the heart
(canine). The principle calcium regulator in the muscle cell is the calcium ion
release channel (aka RyR). Numerous endogenous and exogenous compounds
can affect the way the RyR regulates calcium. In particular, abnormal levels of
oxidants (reactive oxygen species) can oxidize critical thiol groups on the RyR
and modulate its activity. Interestingly, high levels of oxidants are also associated
with numerous bodily disease states including cancers, muscle fatigue/failure,
and CVD.

In this thesis, two important dietary antioxidant compounds, the anthocyanidins
pelargonidin and delphinidin, are evaluated for their effects on regulating the
transport of calcium through the calcium release channel (RyR1) of the
sarcoplasmic reticulum of skeletal muscle. Pelargonidin and delphinidin are
structurally similar with delphinidin only differing from pelargonidin by the addition
of two hydroxyl groups. Both compounds undergo time dependent structural
changes in aqueous solutions at physiological pH and a mixture of more than
i

four structures of each compound can be present in solution simultaneously.
Pelargonidin and delphinidin show distinct differences in their calcium flux
regulating effect on the RyR1. Delphinidin stimulates calcium flux and RyR1
activity whereas pelargonidin can cause both inhibition and stimulation of the
RyR1. The strength of stimulation and inhibition of calcium transport through the
RyR by delphinidin and pelargonidin may be attributed to the structural and
chemical changes in those compounds that occur in solutions near physiological
pH and the subsequent chemical characteristics of the diverse set of structures
that are simultaneously present in solution.
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Introduction

2+

Figure 1.1 Heart Disease, Anti/Pro Oxidants, and Ca

handling

Cardio vascular disease (CVD) causes more deaths than any other disease on
the globe (World Health Organization). Although CVD encompasses numerous
distinct pathological mechanisms, sudden cardiac death (SCD), the abrupt loss
of heart function, is estimated to account for approximately 50% of CVD related
deaths. A majority of the SCD fatalities is attributed to ventricular tachyarrythmias
(VT) (Huikuri, Castellanos, and Myerburg 2001). In an effort to improve the
quality of life for non-fatal CVD victims, reduce CVD deaths, and minimize the
enormous economic costs associated with CVD, extensive epidemiological
studies and laboratory research continue to be funded and performed in hopes to
better explain the pathological molecular mechanisms of CVD.
1

Non-behavioral risk factors of CVD include increasing age, male gender, and
heredity related factors (children of people with heart disease and race related
increased risks). Behavioral risk factors (ones that we can change) account for
over 90% of the risk of heart failures (HF). These factors include cigarette
smoking, abnormal blood lipid levels (high cholesterol), hypertension (high blood
pressure related), diabetes, abdominal obesity, a lack of physical activity, low
daily fruit and vegetable consumption, alcohol over consumption, and
psychosocial index. (AHA-Heart and Stroke Update 4/2009 referenced Lancet.
2004;364:937–952).
Interestingly, a subsequent epidemiological study found an exception to that rule,
the people of southern France consume more fat and smoke more cigarettes
than other countries with a similar incidence of CVD deaths. Additional studies
revealed that the same population also had a slightly different diet which included
higher intakes of vegetables, fruits, and wine. The lower incidence of CVD was
quickly attributed to the constituents of those foods which were abundant in
flavonoid antioxidant compounds. Since then, research has been conducted on
almost every conceivable natural antioxidant to be found in those foods.
Extensive quantitative-structure activity relationship (QSAR) studies have
characterized those compounds for their antioxidant properties. Naturally, those
compounds that exhibited the highest level of antioxidant activity in vitro were
perceived as the best of the best’. These compounds have been studied
extensively in the literature. If antioxidants are the ‘cure’, then it follows that
2

oxidants may be the cause. Researchers targeted native reactive oxidant species
(ROS) and studied their effects on the proliferation of CVD biomarkers in vitro.
The results all seem to imply that ROS cause severe damage to biological
processes and can be attributed to increased incidence of several CVD
pathologies. In addition to the ROS connection, recent studies (Lehnart et al.
2004; Belevych et al. 2007; Belevych et al. 2008; Belevych et al. 2009; Belevych
and Terentyev 2010) related to ventricular tachyarrythmias, a significant
contributor to sudden heart failure, have shown a connection between VT and
increased levels (overload) of calcium (Ca2+) in the heart muscle cell via ‘leaky’
calcium release ion channels (ryanodine receptor). The ryanodine receptor (RyR)
is known to have reactive thiol residues that are extremely sensitive to the
oxidation by ROS and numerous other compounds. Oxidation of these thiols can
causes increased channel activity and Ca2+ conductance (J.J. Abramson and G.
Salama 1988; Jonathan J. Abramson and Guy Salama 1989; J. J. Abramson et
al. 1988; J. J Abramson, Cronin, and G. Salama 1988).
There may indeed be a connection between increased oxidative stress in the cell
(oxidative stress) and abnormal calcium handling by the RyR (calcium overload)
in cardiac myocytes, and deaths by ventricular tachyarrythmias. Dietary
antioxidants that play a part in reducing ROS in the cell may indeed have part in
the decreased incidence of CVD deaths of those populations engaged in higher
(disease) risk activities. However, numerous studies have shown that antioxidant
compounds, especially the good ones, can also act as prooxidants. These
3

antioxidant compounds have also been shown to bind to proteins and protective
enzymes impacting their function (Graziani et al. 1982; Kaldas et al. 2005). The
intention of the investigation of various dietary antioxidants is to characterize that
compound for its potential beneficial properties and its potential deleterious
properties so that fully informed and educated decisions can be made as to
whether or not their benefits outweigh their risks. Due to the possible prooxidant
activity of flavonoid antioxidants, it is clear that before recommendations can be
made regarding their dietary inclusion, any impact that they may have on other
biological systems must be understood. Given the importance of Ca2+
homeostasis in both skeletal and cardiac muscle, the interaction of these
compounds need to be evaluated with regards to their possible modulation
effects on the RyR.

1.1

Oxidative Stress and Calcium Homeostasis in Muscle

Calcium can signal and activate biological processes via dynamic variations in its
concentration within cells. The concentration of free Ca2+ is generally controlled
by its transport in and out of the cytoplasm of cells by ion channel proteins
located in the membrane of the endoplasmic/sarcoplasmic reticulum organelles
within the cell. This Ca2+ movement alters the cytoplasmic (intra-cellular) Ca2+
concentration which in turn impacts Ca2+ binding to various biological substrates.
An important example of Ca2+ signaling is the binding of Ca2+ to specific muscle
4

cell proteins. This interaction is mandatory for our muscles to contract and it also
controls how much force is generated during the contraction. Indeed, without
Ca2+ signaling, our muscles would cease to function and we would die. Improper
functioning of the Ca2+ regulatory proteins can lead to pathological Ca2+
homeostasis conditions that can severely decrease the quality of human life and
also lead to eventual death. The importance of knowing how Ca2+ levels in
muscle cells is regulated and knowing what cause changes in that regulation
cannot be overstated. Studies to determine why muscles malfunction, fatigue,
and fail have consumed researchers for many decades. Although the normal
functioning of the muscle is the result of synergistic cooperation from numerous
proteins that reside in the muscle cell, the main regulatory protein, the one that
controls the fast Ca2+ transient signals within the cell, is called the ryanodine
receptor (RyR). The RyR is, simply put, the valve that opens and closes
controlling the concentration of Ca2+ within the cell. Increased Ca2+levels allow
for the Ca2+ - protein interactions that allow the contractile process of the muscle
to occur. The RyR is very sensitive to the environment within the cell. It is
sensitive to Ca2+ concentrations, the redox environment, binding of other closely
associated proteins, and numerous other endogenous and exogenous
compounds. All of these can have an effect on the way the RyR manages the
Ca2+ level in the cell. This is of utmost importance because too much, or too little,
Ca2+ can cause the concert of cooperation between the cellular proteins to
breakdown which may lead to various pathological conditions and even death. It
5

has been shown that one of the most important cellular conditions, with regards
to proper Ca2+ homeostasis regulation by the RyR, is the redox environment
within the cell (Jonathan J. Abramson and Guy Salama 1989; Jonathan J.
Abramson and Guy Salama 1988; J. L. Trimm, G. Salama, and J. J. Abramson
1986). The redox potential in the cell is related to the relative ease in which the
constituents in the cell environment can reduce (donate electrons or hydrogens
to) the RyR or oxidize (accept electrons or hydrogens from) the RyR. The RyR is
a large homotetrameric membrane protein containing approximately 5000 amino
acids and weighing more than 2.2 megadaltons. The protein contains
approximately 320-400 cytoplasmic, oxidation sensitive, cysteine residues (Xu et
al. 1998). These cysteines have thiol side chains that are very sensitive to
oxidization. When the thiols are oxidized, intra-molecular cystines or cysteineoxidizer adducts can be formed. It has been shown that some of the thiols on the
RyR activate the channel when they are exposed to oxidizing conditions and that
some of the thiols inhibit the channel when oxidized. (Jonathan J. Abramson and
Guy Salama 1988; Jonathan J. Abramson and Guy Salama 1989; A. Dulhunty et
al. 2000). To maintain proper cell function, the redox potential of the muscle cell
environment is kept in a tightly controlled and reduced state by the relative ratios
(redox couple) of a few important endogenous compounds capable of cyclic
redox states. The redox state of the cellular environment can be impacted by all
of the cellular redox couples present with each couple contributing via an additive
effect. However, due to its high concentration and respective reducing capacity,
6

the glutathione disulfide/glutathione (GSSG/2GSH) couple is considered to be
the main redox buffer of the cell and the state (value) of this couple alone is
typically used as an indication of the state of the redox environment of the cell
(Schafer and Buettner 2001). The relative concentration of GSH present in the
cell, and consequently, the redox environment is impacted by the invasion of
oxidative species. The main endogenous oxidative species are derivatives of
either oxygen or nitrogen. In particular, oxidative free radical compounds,
hydrogen peroxide, and derivatives of nitric oxide. These are commonly referred
to as reactive oxygen species (ROS) or reactive nitrogen species (RNS). ROS
are natively generated and released from the oxidative phosphorylation
processes of the mitochondria in the cell and by other mechanisms such as
xanthine oxidase (XO) and NAD(P)H oxidases. ROS can impart their damage by
further increasing ROS levels via autoxidation reactions that further increase the
levels of oxidants by directly attacking and altering (taking or donating electrons)
cellular membranes and proteins causing altered function (Sen and Packer 2000).
Increased levels of ROS can be generated during increased levels of exercise,
exposure to environmental pollutants, and consumption of pro-oxidant
compounds in food and beverages. In order to keep the redox environment
tightly controlled (and in a reduced state), the body has a host of endogenous
antioxidant defenses against these oxidants. Antioxidants are tasked with
neutralizing the ROS by donating or accepting electrons or hydrogens to or from
the ROS minimizing or nullifying its reactivity before the ROS reaches critical
7

cellular substrates. In doing so, the antioxidant generally becomes a radical
species itself but one that is more stable and relatively unreactive as compared
to the original ROS. The main endogenous antioxidant compounds of the cell are
glutathione (GSH), the glutathione peroxidase system, CoEnzyme Q, superoxide
dismustase (SOD), and catalase. This defense network is effective at protecting
against various ROS under normal cell conditions but high levels of oxidants,
generated during times of high oxygen consumption (strenuous exercise) or as a
result of prooxidant intake (air pollutants or high fat diets), can overwhelm the
endogenous defenses. These increased levels of oxidant compounds can easily
overwhelm the endogenous antioxidants inducing a state of oxidative stress in
the cell (M. J. Davies and Dean 1997; Fridovich 1978; K.J. Davies et al. 1982).

1.2

Oxidative Stress and Disease

It is now well accepted that elevated ROS levels are associated with numerous
bodily disease states including numerous cardio vascular diseases including but
not limited to atherosclerosis pathology (Khatri et al. 2004), cardiac hypertrophy
(Higuchi et al. 2002), and myocardial lipotoxicity (S. Sharma et al. 2004). It is
also connected with a variety of cancers, Alzheimer’s Disease, inflammatory
diseases (Hidalgo and Donoso 2008; Zima and Blatter 2006; Belevych et al.
2009) as well as skeletal muscle fatigue and failure (Moopanar and David G
Allen 2005). Lipid peroxidation and sulfhydryl group oxidation during ischemia8

reperfusion can lead to abnormally high cell Ca2+ levels and contractile
dysfunction (Dhalla et al. 1999). Improper Ca2+ handling in the heart muscle has
been connected to atrial arrhythmogenesis and contractile dysfunction in dogs
with congestive heart failure (CHF) (Yeh et al. 2008). Evidence has shown that
reactive oxygen species (ROS) alter calcium pump function (Kourie 1998; Kaplan
et al. 2003), alter calcium current reduction in L-type calcium channels (Guerra et
al. 1996), and decrease contractility via altered calcium handling (He et al. 2003)
in cardiac myocytes. Recently, there have been numerous studies pointing to
Ca2+ overload via improper Ca2+ handling by the RyR as an underling cause of
arrhythmias and sudden cardiac death (Belevych et al. 2007; Belevych et al.
2009).

1.3

The Flavonoid Antioxidant – Calcium Homeostasis Connection

Figure 1.2 Structure of Quercetin

9

The effects of flavonoid compounds on the activity of the RyR need to be
evaluated before they can be considered viable nutraceuticals. These
compounds may be good antioxidants and even promote anticancer effects but if
they or their radical species react directly with the RyR or other Ca2+ homeostasis
associated proteins, they may cause harmful calcium overloading effects.
Studies on the interaction of flavonoids with the RyR are sparse. However, one
popular flavonoid antioxidant, quercetin, has been shown to activate Ca2+ release
from the SR skeletal muscle (D. H. Kim, Ohnishi, and Ikemoto 1983). Quercetin
is a popular dietary antioxidant found in numerous vegetables, fruits, nuts, and
teas. It has been extensively studied due to its excellent antioxidant properties
and inclusion in numerous foods. Lee et. al. (Eun Hui Lee, Gerhard Meissner,
and Do Han Kim 2002) showed that quercetin activates single RyR channel open
probability (EC50 of 91.0 +/- 15 µM at 10 µM Ca2+) more effectively than the well
known RyR activator caffeine (EC50 of ~2.93 mM at 10 µM Ca2+). Quercetin also
exhibited a higher maximal open probability (Po=0.89 at 250 µM) as compared to
caffeine (Po=0.66 at 9 mM). Quercetin is effective at stimulating the RyR but it
didn’t exhibit any inhibitory actions. With regards to the redox sensitivity of the
RyR, further tests were conducted to assay the effects of quercetin in the
presence of the reduced and oxidized forms of glutathione (a cellular redox
couple and as well as an endogenous antioxidant). The results showed that the
effects of 5 mM GSSG (a RyR1 stimulant) plus quercetin on the RyR1 were not
reversed by mM GSH (a known RyR1 inhibitor (Anthony C Zable, Terence G
10

Favero, and Jonathan J Abramson 1997)). This may indicate that quercetin does
not work via a redox dependent pathway. They also showed that the known
stimulatory effects of K+-ATP on the RyR partially inhibited the stimulation by
quercetin indicating that they may share the same binding site or that the effects
of ATP on the channel may allosterically affect quercetin binding. These results
are interesting from the stand point that quercetin appears to have a direct effect
on the RyR yet not via a redox pathway. This is surprising since quercetin has a
catechol group (ortho hydroxyls) on its B-ring which is notorious for being
oxidized to semiquinone radicals and quinones which have prooxidant properties
and directly react with protein thiols (Metodiewa et al. 1999; Boots et al. 2003).

11

1.4

The Anthocyanidins

Figure 1.3 Anthocyanidin Structure

Anthocyanidins are a subclass of flavonoids and are best known for the beautiful
colors they impart to nature. Based on their simplicity and wide ranging
abundance, the anthocyanidins delphinidin (Dp), cyanidin (Cy), and pelargonidin
(Pg) are considered the three main anthocyanidins of more than 500 that are
known to exist. They are responsible for most of the intense oranges, reds, blues,
and purple colors exhibited in leaves, flowers, and fruits (J. B. Harborne, T. J.
Mabry, and H. Mabry 1975). The chemical and biological properties of these
compounds are very complex. Unlike other flavonoids, anthocyanidins are
structurally unstable in weakly acidic to alkaline solutions. Upon exposure to
these conditions, they will immediately start to transform into several different
structural forms each with distinct chemical properties. The relative proportions of
these forms is dependent on the pH of the solution and the specific
12

functionalization of the compound (Brouillard and Delaporte 1977; Brouillard and
Dubois 1977; Brouillard, Iacobucci, and Sweeny 1982; Jurd 1963; Jurd and
Geissman 1963; Jurd 1964; Jurd and Waiss 1965) (for more information see
chapter 3). Along with the possible health benefits previously mentioned, these
anthocyanidins are interesting and commercially valuable due to their ability to
act as food colorants and food preservatives (antioxidants).
1.4.1 Pelargonidin and Delphinidin – The Antioxidants

Figure 1.4 Structures of pelargonidin and delphinidin
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Although both pelargonidin (Pg) and delphinidin (Dp) exhibit good antioxidant
properties as compared to the well accepted antioxidant vitamin E, delphinidin is
dominantly superior to pelargonidin as an antioxidant. Delphinidin’s antioxidant
quality is attributed to its tri-hydroxyl structure in its B-ring. Those groups are very
easily oxidized and its mechanism of antioxidant action is probably by electron
donation and formation of a semiquinone moiety. The donation of a second
electron then will form a quinone. (S. A. Van Acker et al. 1996; A. Sekher
Pannala et al. 2001). Pelargonidin only has a mono-hydroxyl B-ring and is a less
effective antioxidant. Its mechanism of action is probably by donation of an
electron and subsequent formation of a phenoxyl radical (Galati et al. 1999;
Ananth Sekher Pannala et al. 2001).
Both Pg and Dp exhibit superoxide and hydroxyl scavenging activity and can
inhibit hydrogen peroxide induced lipid peroxidation. In a study of pomegranate
extract, a hypoxanthine-xanthine oxidase superoxide generating system where
DMPO-OOH spin adducts (indicator of superoxide concentration) were measured
by ESR, Dp and Pg both exhibited scavenging properties with Dp being over two
orders of magnitude better than Pg (IC50=0.8µM and 130µM respectively). They
also scavenged hydroxyl radicals with Dp being more effective than Pg although
their scavenging properties may involve indirect rather than direct scavenging
and possibly by more than one scavenging mechanism (Noda et al. 2002)

14

Dp and Pg also were shown to inhibit H2O2 induced lipid peroxidation in rat brain
homogenate when H2O2 and Dp and Pg were incubated together with the brain
substrate for 60 minutes (IC50=0.7µM and 85µM respectively) (Noda et al. 2002).
In a similar extract study (grape seed, etc), Dp and Pg also exhibited (with one
exception) scavenging properties for superoxide, hypochlorite ion, hydroxyl
radical, and linolenic acid with Dp, again, being a better scavenger in all cases.
Pg did not exhibit superoxide scavenging properties in this study (Wada et al.
2007).
Another study assessed the ability of Pg and Dp to scavenge the DPPH (1,1Diphenyl-2-Picrylhydrazyl) radical (4 min incubation in MeOH), prevent MeLo
(Methyl Linoleate) emulsion (10% oil in water) hydroperoxide formation after 72
hours (pH~5.5), inhibit Cu initiated hexanal formation from oxidation of LDL (2 hr
incubation @ pH7.4), and prevent bulk MeLo (100%) hydroperoxide formation
after 72 hours. Generally, Pg and Dp both exhibited antioxidant activity with Dp
being a better antioxidant. However, at a low concentration (2.5µM), Dp exhibited
prooxidant activity but Pg was still an antioxidant in the LDL assay. They
attributed the better antioxidant property of Pg to the fact that it has low polarity
and thus may have better access to the lipid peroxidation site of the LDL (they
sited similar results from another study). The researchers also admitted that the
method of antioxidant action at higher concentrations may be due to hydrogen
donation to the tocopheryl radical back to tocopherol (vitamin E) or by
scavenging radicals and protecting tocopherol from consumption. Additionally,
15

the anthocyanidins may bind with apolipoprotein B and prevent its subsequent
binding to LDL thus blocking Cu catalyzed oxidation. Interestingly, they also
noted that polar antioxidants (hydrophilic) are generally are more efficient in bulk
oils than non-polar antioxidants (hydrophobic). This is due to a higher
concentration or accumulation of a hydrophilic compound that accumulates at the
oil water interface (Kahkonen and Heinonen 2003).
The radical scavenging ability of Pg and Dp is pH dependent. In a study by
Borkowski et al., the TEAC antioxidant values (antioxidant action relative to
Trolox) are measured for Pg and Dp (and several other anthocyanidins). The
TEAC assay is based on the ABTS*+ radical and the ability of the antioxidant to
scavenge it and thus reduce its characteristic absorption spectrum. This
particular compound was used due to its stability in a wide range of pHs. (2-9.5).
Results basically indicated that Dp is a powerful antioxidant (several times better
than Trolox) and its increase in scavenging activity is related to the
deprotonations of its C4’ hydroxyl (pKa1~5.3 (experimentally determined)) and its
C5 hydroxyl (pKa2~6.73 (computationally predicted)). Pg on the other hand had
an activity similar to Trolox but did not show a strong increase in activity with the
deprotonation of C5.(pKa1~5.79 (experimentally determined)) and the
deprotonation at C4’ (pKa2~7.05 (computationally predicted)) (Borkowski et al.
2005).

16

1.4.2 Pelargonidin and Delphinidin – The Prooxidants
As hinted at in the previous section, both Pg and Dp can exhibit prooxidant
properties. Delphinidin’s pyrogallo group in its B-ring is highly oxidizable and
autoxidation of this group is possible at physiological pH. Autoxidation is
accompanied by generation of superoxide and hydrogen peroxide (Hodnick et al.
1986; Hodnick et al. 1988). This property may also be enhanced by delphinidin’s
metal chelating ability which is also known to catalyze the autoxidation of
(similarly oxidizable) catechol groups (dihydroxy group) (Vanacker et al. 1995;
Canada et al. 1990; Dangles, Fargeix, and Dufour 2000).
Pelargonidin, with only a monohydroxyl group in the B-ring, does not exhibit
autoxidation and doesn’t chelate metals. Its reduction in hydrogen peroxide
induced lipid peroxidation activity may be due to a different oxidation mechanism
(Saskia A. B. E Van Acker et al. 1996). In one study, it was found that the
phenoxyl radicals of similarly structured compounds with a mono-hydroxyl
substituted B ring redox cycled and caused extensive GSH oxidation at pH~7 to
form thiyl- radicals which reduced oxygen. Surprisingly, flavonoids containing a
catechol B-ring did not show the same oxidative properties (Galati et al. 1999).
In a LDL oxidation assay (Satue-Gracia, Heinonen, and Frankel 1997), both Dp
and Pg act as prooxidants when 3uM copper is used as an oxidation initiator.
Interestingly, when 10µM copper is used, Pg acts as an antioxidant and Dp
continues to be prooxidant. It was noted that more work was needed to be able
17

to propose a mechanism for why Pg changes its antioxidant/prooxidant activity
with various copper concentrations.

18

1.5

This Thesis

Due to the importance of understanding the effects that potential nutraceuticals
have on the Ca2+ homeostasis in muscle tissue, this thesis will attempt to
evaluate the modulation effects that pelargonidin and delphinidin have on the
ryanodine receptor calcium release channel of skeletal muscle.
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2

Muscle Structure and Function

At a macro level, muscles are well defined organs capable of generating great
force when stimulated to do so. Some of these stimuli are consciously controlled
(voluntary muscle) and some are not consciously controlled (involuntary muscle).
The heart (cardiac muscle), the iris of the eye, the arrector pili of the skin, the
bladder, blood vessels, the gastrointestinal tract, are all examples of organs that
contain involuntary muscle. Skeletal muscle is the only muscle tissue that is
consciously controlled. It is responsible for locomotion, posture, voluntary eye lid
movement, and sphincter control to name a few. Both cardiac muscle and
skeletal muscle are classified as striated muscle due to the striated appearance
of muscle fibers when viewed under the light microscope. These striations are
due to a repeating, end-to-end, pattern of contractile proteins at the molecular
level of the tissue. There are three types of muscle tissue: cardiac, skeletal, and
smooth. They all have unique characteristics depending on the function for which
they are designed. For instance, non-striated smooth muscle lacks the end-toend pattern of contractile proteins as mentioned. The random orientation and
alignment of the contractile proteins of smooth muscle allows it to accommodate
larger variations in stretch while still maintaining contractility. These
characteristics are favorable in organs such as the bladder and the GI tract. On
the other hand, the end-to-end and aligned orientation characteristics of skeletal
and cardiac muscle allow them to generate large forces with longer contractile
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distances. These characteristics are required for generating large movements
like bending a leg and also for generating high fluid pressures within the heart
ventricles.
2.1

Muscle Structure

The original work presented in this thesis is most closely related to the function of
the calcium release channel of skeletal muscle and thus it will be the primary
muscle tissue discussed. However, probably the most benefit to society can be
obtained if these types of studies are applied to cardiac muscle. For that reason,
the finer details of the function of cardiac muscle may also be discussed. Smooth
muscle is also very important with regards to human anatomy and physiology,
but due to the limited scope of this thesis, it will generally not be discussed.
2.1.1 Skeletal Muscle Macro Structure
Skeletal muscle is composed of both muscle tissue and connective tissue and is
highly compartmentalized. Each compartment is contained and protected by
fibrous connective tissue (epimysium, perimysium, and endomysium). The
largest of these compartments contains the whole macro muscle (muscle belly)
and is surrounded by the epimysium. The muscle belly is composed of fascicles
which are many smaller bundles of parallel strands encased in the perimysium.
The fascicles contain groups of the long muscle cell which also known as the
myofiber.
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2.1.2 The Muscle Cell Structure
Skeletal myofibers span the complete length of the bulk muscle that contains it.
They range from 10 µm to 100 µm in diameter and up to 30 cm long (depending
on the macro muscle length). Due to their long shape, myocytes are also referred
to as myofibers. Myofibers are surrounded by the endomysium which provides
the fiber access to capillaries and nerves. Layered underneath and proximal to
the endomysium is the cell membrane of the myofiber, the sarcolemma. The
sarcolemma is the plasma membrane that contains the intracellular fluid of the
myofiber called the sarcoplasm. The sarcolemma is designed to receive nervous
system stimuli and conduct that signal throughout the cell via membrane
invaginations (transverse tubules or T-tubules) that project directly into the
cylindrically shaped cell at locations associated to the Z-disks of the sarcomere
(contractile sub-unit of the myofiber). Internal to the sarcolemma are highly
aligned and orientated filamentous motor proteins (myofibrils). Surrounding the
myofibrils throughout the myofiber resides an organized and highly functional
organelle network called the sarcoplasmic reticulum (SR). The SR is designed to
act as a storage compartment for Ca2+ . The SR extends from T-tubule to Ttubule and the group of organelles where two SR membranes from adjacent
sarcomeres meet a t-tubule is called a triad (SR membrane: T-tubule: SR
membrane). Proximal to the T-tubule, the SR exhibits an enlargement or sac
which is referred to as the terminal cisternae (TC). The matrix of SR between the
T-tubules and proximal to the longitudinal center of the myofibrils is the
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longitudinal SR. The myofiber is composed of an end-to-end chain of many
contractile sub-units called the sarcomere. The sarcomere is a highly organized
and complex arrangement of numerous proteins. Filamentous actin (f-actin or
thin filament) and filamentous myosin (f-myosin or thick filament) are the
contractile proteins of muscle. Tropomyosin and troponin are the primary
regulatory proteins. Additionally there are structural proteins that help maintain
the form of the muscle cells. Titin is an elastic protein filament that runs through
the center of the myosin filaments and emerges from the end of the filament to
connect to the Z-disks proximal to each end of the filament. The Z-disks are
composed of an elastic protein filament called connectin. The Z-disks are the
highly light refracting portion of the fiber that gives rise to the striated appearance
of the muscle. Z-disks provide direct anchorage for both the titin and the actin
filaments. The area between two Z-disks that contains both f-actin and f-myosin
is the sarcomere.
2.1.3 The Sarcomere
F-myosin filaments (thick filaments) are about 15 nm in diameter and are made
of hundreds of motor proteins molecules, myosin II (hence forth referred to as
just myosin). One molecule of myosin is comprised of two polypeptide chains
intertwined to form a golf club shaped structure where one end is the tail and the
other end the head. A myosin filament is several hundred of these golf club
shaped molecules linked together end to end with the tail sections intertwined
and the heads extending outward from the filament. Thin filaments are about 7
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nm in diameter and are made up of two twisted strands of f-actin (filamentous
actin). F-actin is a string like assembly of globular actin (G-actin) protein
molecules. Each G-actin molecule has an active site that can bind to the head
domain of the myosin molecules of F-myosin. Wrapped around the thin filament
is another long polypeptide chain of proteins called tropomyosin. Tropomyosin
has the function of blocking the binding of the myosin heads to the G-actin.
Bound to the tropomyosin is a smaller and intermittently spaced calcium binding
protein called troponin. Troponin has the function of binding calcium, undergoing
a conformational change, and moving the tropomyosin filament which allows
myosin to bind to the G-actin sites. Troponin has three sub-units and is bound to
both the thin and thick filaments. The three sub-units are: TnI (bound to actin),
TnT (bound to myosin), and TnC (calcium binding sub-unit).
When the sarcomere is viewed under a light microscope, the varying densities
and refracting properties of the protein structures can be observed, and thus
distinguished. The area spanning adjacent sarcomeres that includes the Z-disk
but does not include the F-actin is called the “I Band”. The area that spans the
length of one F-myosin filament is called the “A Band”, the area near the center
of the F-myosin that does not overlap F-actin is called the “H zone”, and the area
where the F-actin meets at adjacent sarcomeres is connected is called the Z-disk
(as explained previously). The length of a sarcomere is approximately 1.7 µm in
the contracted state and 2.2 µm in the extended state. The F-mysoin’s structure
is such that the myosin heads orient themselves in a corkscrew shape along the
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filament. This gives rise to a repeating pattern with six crossbridge head groups
positioned in a radial pattern at multiples of 60 degrees. These repeating patterns
are oriented such that the crossbridge heads align with each other along the
length of the F-mysoin. F-actin and F-mysoin are orientated in hexagonal pattern
when viewed as a cross section. There are six F-actin filaments surrounding
each F-myosin filament, one F-actin per crossbridge head row and one F-actin
filament may bind to more than one F-actin filament. This orientation is
maintained throughout the myofiber which contains hundreds of myofilaments
per fiber.
2.1.4 The Sarcoplasmic Reticulum (SR)
The SR is an organelle in the myocyte that has the primary function of storing
Ca2+. The SR is a webbed network of an enclosed membranous system
extending along the length of each sarcomere. As previously noted, the SR has
two main structural and functional regions: 1) the terminal cisternae are the
enlarged sac like structures nearest to the T-tubules and 2) the longitudinal SR is
located along the length of the sarcomere. The area where the TC meets the ttubule is highly functional and complex and it’s commonly referred to as the
triadic junction, the dyadic junction, or (when referring to the SR specifically in
this region) the junctional SR. The TC region of the SR contains a large amount
of the Ca2+ binding protein calsequestrin. Calsequestrin is able to bind up to 50
Ca2+ ions per monomer and this binding of free Ca2+ increases the total Ca2+
storage potential of the SR. The junctional SR is the home of the main regulatory
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Ca2+ ion channel, the ryanodine receptor (RyR) (see next section more for
additional detail) as well as other associated transmembrane proteins such as
junctin and triadin. On the T-tubule, there resides a voltage gated Ca2+ ion
channel called the dihydropyridine receptor (DHPR) which is also an important
player in the functionally of muscle. Located primarily in the longitudinal SR is the
Ca2+ ATPase pump (aka SERCA). There are almost 100 fold more SERCA
pumps than RyRs in the SR. The Ca2+ ATPase is responsible for accumulating
Ca2+ into the SR which allows the muscle to relax.

2.1.5 Muscle Contraction
The signal for a muscle to contract is sent from the brain via a neuron/axon to the
neuromuscular junction. There, the signaling action potential opens voltage gated
Ca2+ ion channels in the axon’s plasma membrane which causes the internal
levels of Ca2+ to increase. The elevated Ca2+ causes intracellular vesicles
containing acetylcholine (ACh) to fuse with the cell membrane and, through
exocytosis, dump the Ach into the synaptic cleft. ACh then binds to ligand gated
Na+ ion channels causing them to open and allow the subsequent influx of Na+ in
to the cell. This process causes the immediate opening of K+ ion channels and
the subsequent efflux of K+ out of the muscle cell. Because of concentration
differences, more Na+ flows into the cell than K+ flows out of the cell and this
causes an electrochemical depolarization across sarcolemma. This
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depolarization self-propagates over the whole muscle cell and down the Ttubules. The depolarization of the T-tubules signals for the opening of the
resident voltage gated L-type Ca2+ ion channel, the dihydropyridine receptor
(DHPR). In the skeletal muscle cell, the DHPR is believed to be mechanically
coupled to the ryanodine receptor and the opening of the DHPR has shown to be
the determinate cause of the opening of the ryanodine receptor. In cardiac
muscle, the DHPR is not structurally associated with the ryanodine receptor. The
opening of the DHPR allows Ca2+ to enter the cell from the cytoplasm. The
process of Ca2+ influx through the DHPR and subsequent elevation in Ca2+
concentration is responsible for cardiac ryanodine receptor activation. This
process is called “calcium induced calcium release”. The elevated levels of
cytoplasmic Ca2+ causes Ca2+ binding to troponin which moves tropomyosin and
allows myosin access to the actin binding sites. Myosin binding to the G-actin
initiates the conformation change of myosin from a high energy conformation to a
low energy conformation. This is commonly referred to as the power stroke. This
change pulls the thin filament along the thick filament. The thin filament is
attached to the Z-disks on each end of the sarcomere and the power stroke
causes the sarcomere to shorten or contract. Thousands of these cellular
contractions occurring in unison causes the muscle contraction we’re familiar
with at the macro level. After the power stoke occurs, the low energy
conformation of myosin remains attached to f-actin until an ATP molecule binds
to it. If there isn’t any ATP available, the muscle remains in this contracted state
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(rigor). If ATP is available, it binds to the myosin head and the head de-binds
from actin. Once it is free, myosin can hydrolyze the ATP into ADP and Pi . The
hydrolysis of ATP provides the energy for myosin to change back into the high
energy conformation and then rebind to actin. This cyclic process is referred to
as cross-bridge cycling. When the signal from the central nervous system stops
initiating depolarizations of the cell membrane, the DHPR closes and the RyR
closes as a result. Ca2+ concentrations are decreased and troponin changes its
conformation to allow tropomyosin to block actin-myosin binding. This is the
resting state of the muscle.
2.1.6 Excitation-Contraction Coupling
Excitation-Contraction Coupling (EC coupling) is the term used when describing
the process of converting the cell depolarization into the actual muscle
contraction. Although the overall process of the sliding filaments (sliding filament
theory) is well established and accepted, the mechanism in which the DHPR
communicates the depolarization signal to the RyR in skeletal dyads still remains
uncertain. Cardiac dyadic junctions are organized differently than skeletal dyadic
junctions. RyRs have the ability to self-organize into repeating patterns and do so
in the junctional SR of both cardiac and skeletal muscle. Cryo-EM images of
dyads have shown that the DHPRs of cardiac dyads are not arranged in any
pattern with respect to the RyRs. They oppose the RyRs but in a random way.
However, the DHPRs of skeletal dyads are arranged so that every other RyR1 is
directly opposed to a cluster of four DHPRs and each cluster is associated with
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one monomer of the RyR (Block 1988). It has been shown that cardiac RyRs
don’t require the interaction with the DHPR to release large stores of Ca2+ from
the SR. Instead, fast increases of Ca2+ near the junctional SR causes Ca2+
release from the RyR. For this reason, the release of Ca2+ from the SR of cardiac
SR has been characterized as calcium induced calcium release (CICR). For
skeletal dyads, the mechanism is more complex. The highly organized
arrangement between the DHPR and the RyR implies a high level of association
between them and indeed it has been shown that in functional triads, the
molecular modification of what is called the II-III loop or the DHPR can cause the
RyR to cease to release Ca2+ from the SR. Studies of simpler protein complexes
like the voltage dependent K+ ion channels have shown that cell membrane
depolarizations trigger movements in voltage sensing domains and those
movements can be trans-located across the membrane (Jiang, A. Lee, et al.
2003; Jiang, Ruta, et al. 2003). Together with the organized DHPR-RyR1
structures, it is hypothesized that charge dependent movements in the DHPR
directly interact with the RyR and trigger the opening of the channel causing Ca2+
release. However, there are still a lot of unanswered questions stemming from a
wealth of research and discussion and the understanding of the exact
mechanisms required for EC coupling is still undetermined.
2.2

The Ryanodine Receptor

Ryanodine receptors are the largest membrane ion channels known. Three
mammalian RyR isoforms are known to exist. These include the skeletal muscle
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RyR (RyR1), the cardiac muscle RyR (RyR2), and the smooth muscle RyR
(RyR3). All of the isoforms have a sequence homology of approximately 70%.
The skeletal RyR1 (rabbit) sequence consists of 5,037 amino acids and has a
molecular weight of 565,223 Da. The complex is a homotetramer of four identical
subunits with a total weight of ~2.3 MDa.
2.2.1 The Ryanodine Receptor – Structure
Knowing the ‘exact’ structure of a dynamically functional protein can give vast
insight as to the biophysical mechanics and chemistry of the molecule.
Unfortunately the RyR is too small to be viewed under a light microscope and too
large and complex to solve with traditional structural techniques such as x-ray
crystallography. Original freeze-fractured electron microscopy images of skeletal
triads by Ferguson et al. (Ferguson, Schwartz, and C Franzini-Armstrong 1984)
were among the first to show the square foot structure of the skeletal RyR. They
also were able to show the significant association of the RyR and DHPRs in
skeletal muscle (Clara Franzini-Armstrong and Kish 1995). Since then, cryo-EM
of single particles has emerged as a very useful technique to study the structure
of these particles. Utilizing fluorescent probes with EM can also give us an idea
of where important modulators bind on the macro structure. Sample preparation
includes solubilizing the protein with detergent to separate it from the SR and
then freezing it in liquid ethane (~ -88oC). Many images (1,000 to 100,000) are
computationally aligned and averaged and screened for artifacts to obtain the
final result. Since the proteins have many different orientations, images from
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different perspectives are obtained and images can be reconstructed to produce
3-D images (Serysheva, Chiu, and Ludtke 2007). Capturing images of different
conformational states is also possible by putting the RyR in an environment that
favors a particular conformation prior to freezing it. Sub-nanometer resolutions
have now been achieved by several groups (Ludtke et al. 2005; Serysheva et al.
2008; Serysheva et al. 2007) and it has been shown by some of these same
groups that resolutions of 6-10 Å is adequate for determining secondary
molecular structures (α-helices and β-sheets).
2.2.2 Sub-nanometer cryo-EM Structures
The RyR has a mushroom shape with a large cytoplasmic (CY) head and a
smaller transmembrane (TM) stem. From above it has four-fold symmetry
(quatrefoil shaped). The CY region is 280 Å x 280 Å x 120 Å with the 120 Å being
the dimension from the SR membrane to the top of the channel. The CY region is
of low amino acid density and shows numerous possible locations for ligand
binding. The TM region is much more dense and has dimensions of 120 Å x 120
Å x 60 Å. The orientation of the TM region is rotated approximately 40 degrees
with respect to the CY region (Ludtke et al. 2005). At the corners of the CY
structure, there are clamp shaped regions. These ‘clamps’ are connected to
central rods by dense bridging structures. Images have been captured with the
channel in both open and closed states. When going from the closed to the open
channel state, conformational changes are apparent with: the removal of amino
acid density in the center of the channel (pore opening), CY clamps change from
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a closed shape to an open clamp shape, the TM domain rotates relative to the
CY domain by ~4 degrees, and mass movements are seen in the central cavity
and TM region (Orlova et al. 1996; Serysheva et al. 1999). The binding sites of
several channel modulators have been mapped to the RyR structure by
fluorescent tagging techniques. Calmodulin (Samsó and Wagenknecht 2002),
FKBP12 (Samsó, Shen, and P. D Allen 2006), and other ligand binding sites
have been located in the distal CY structure between clamp regions (‘handle’
region). Additionally, RyR mutations associated with malignant hypothermia and
central core disease are known to be within the clamp region. This information
supports beliefs that the channel is gated by allosteric means.
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Figure 2.1 Cryo-EM reconstruction of RyR1 in open and closed states (Orlova, E. et al.
Nature Structural Biology v3(6) 547-52. 1996) .
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2.2.3 The Ryanodine Receptor Function
2.2.3.1 Associated Proteins and Endogenous Modulators of the RyR
Dihydropyridine Receptor (DHPR): The DHPR is an L-type voltage gated Ca2+
ion channel located in the T-tubule membrane of the dyadic junction. It is highly
associated with RyR1 both from a structural organization relationship and in
function. It is the primary Ca2+ release initiator and is required for proper RyR1
function. The DHPR is less associated with RyR2. The structural organization is
lacking and a direct interaction with the DHPR is not required for RyR2.
FKBP12/12.6: FKBP12 is a 12kDa protein associated with the RyR1 (FKBP12.6
is associated to RyR2) and binds in the ‘handle’ region at a ratio of four FKBP
molecules per RyR (one FKBP per monomer). FKBP12 stabilizes the RyR and
disassociation of FKBP from the RyR causes an increase in Ca2+ conductance.
Calcium: The RyR is a Ca2+ activated Ca2+ channel. The response of the RyR to
free Ca2+ concentration is bell shaped. Ca2+ conduction through the RyR is
minimal at low (<1 µM ) concentrations, maximal ~100 µM (depending on
conditions), and again minimal above 1000 µM free Ca2+ (J.S. Smith, Coronado,
and G. Meissner 1986). This type of behavior is typically attributed to more than
one binding site with each binding site having either differing ligand affinities or
conformational accessibility limitations. Due to the small size of Ca2+, the
accessibility option is probably not a concern. Therefore, the belief is that there is
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a high affinity activating binding site that gets populated at low Ca2+
concentrations and a low affinity inhibition binding site is populated at high Ca2+
concentrations.
Calmodulin (CaM): CaM is a Ca2+ binding protein with a molecular weight of
16.8 kDa. CaM’s structure is made up of four Ca2+ binding domains (EF-hands)
and it can bind four Ca2+ ions per protein. It is known to bind with RyR1 and
cause stimulation at low Ca2+ concentrations and inhibition at high Ca2+
concentrations. Binding with RyR2 causes only channel inhibition (J. S Smith,
Rousseau, and G. Meissner 1989; Tripathy et al. 1995).
Magnesium (Mg2+): Mg2+ is a known inhibitor of the RyR. Due to its similar
nature and size as compared to Ca2+, it is believed that Mg2+ may compete with
Ca2+ for the high affinity inhibition sites which is believed to cause inhibition of the
channel with high concentrations of Ca2+ (J.S. Smith, Coronado, and G. Meissner
1986).
Adenosine-5'-triphosphate (ATP): ATP as well as other adenine nucleotides
(cAMP, ADP, AMP, etc) are stimulators of the RyR (G. Meissner, Darling, and
Eveleth 1986).
Glutathione (GSH): GSH is a tri-peptide of glutamate, cysteine, and glycine.
GSH is a good reducing agent and is one of the principle endogenous
compounds tasked with keeping the cellular redox status in check. Its
concentration in the cell varies between 1 mM and 10 mM. When in an oxidizing
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environment, it can be oxidized and form glutathione disulfide (GSSG). GSH
(reduced form) inhibits the RyR and GSSG (oxidized form) stimulates the RyR.
The two forms show to be competitive and therefore it is believed that they both
act on the same regulatory sulfhydryls on the RyR. (A C Zable, T G Favero, and
J J Abramson 1997)
Superoxide (O•– ): Superoxide is commonly generated by leaks in the ETC
(electron transport chain) pathway of the mitochondria in cells and is a major
contributor to oxidative stress. Superoxide has shown to decrease calmodulin
content and increase Ca2+ efflux from heavy SR. It was also shown that single
channel activation was dependent on the presence of calmodulin. (Kawakami
and Okabe 1998)
Hydrogenperoxide (H2O2): H2O2 was shown to induce release from actively
loaded SR vesicles at >1 mM concentrations and induce a bi-phasic response in
[3H]-ryanodine binding assays (activation range: 100 µM – 10 mM). (T G Favero,
A C Zable, and J J Abramson 1995)
Junctin and Triadin: Junctin is a ~27kDa MW membrane protein and Triadin is
a 95kDa MW membrane protein (Fan, Brandt, and Caswell 1995). Junctin and
Triadin both bind to the RyR and are believed to help associate calsequestrin to
the RyR (J. M Lee et al. 2004; Goonasekera et al. 2007; Jones et al. 1995;
Angela Dulhunty, Lan Wei, and Nicole Beard 2009). They both have been shown
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to activate the RyR when added to the luminal side of the channel and seem to
activate at independent sites (L. Wei, Gallant, et al. 2009).
Calsequestrin (CSQ): CSQ is a 44 kDa Ca2+ binding protein located in the
lumen of the SR that effectively binds up to 50 Ca2+ ions per molecule
(MacLennan and Wong 1971). CSQ has been found to increase channel activity
when removed from the of RyR complex and inhibit activity when added back in
to the luminal space (N. A Beard et al. 2002). There are two CSQ genes, CSQ1
(fast and slow twitch skeletal muscle) and CSQ2 (slow twitch skeletal and
cardiac). Single channel studies have shown that CSQ1 may inhibit RyR1 but
stimulate RyR2 (L. Wei, Hanna, et al. 2009) It should be noted that numerous
studies of the interaction between RyR, CSQ, junctin, and triadin are being
reported in current literature and important and relevant information regarding the
interaction of these protein complexes are being discovered.
2.2.3.2 Non-Endogenous Modulators
Ryanodine (Ry): Ryanodine is an alkaloid found in the plant Ryania speciosa of
South America. It has a high affinity to the RyR (and thus the reason for its name)
and locks it in a varying degree open state depending on concentration. (I. N.
Pessah et al. 1986; Lai et al. 1988).
Ruthenium Red: Ruthenium is a potent channel inhibitor and can block channel
activity at sub micromolar concentrations. It is commonly used to verify the
presence of the RyR in assays (Ma 1993).
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4-chloro-m-cresol (4-CmC): 4-CmC a drug preservative stimulates (~75-100
µM) [3H]-ryanodine binding and planar bilayer activity. (Herrmann-Frank et al.
1996)
Anthraquinones: Doxorubicin, mitoxantrone, daunorubicin, and rubidaxone all
stimulate RyR1 activity by a direct interaction with the caffeine and the Ca2+
binding sites. (J. J. Abramson et al. 1988)
2.2.3.3 Redox Activity Characteristics
The RyR has approximately 100 cysteines per monomer (Takeshima et al. 1989)
with approximately 80 of those accessible to be oxidized. Cysteines are highly
reactive and well known to be redox active compounds in other biological
molecules. The RyR has also been shown to be very sensitive to its redox
environment. When the RyR is subject to an oxidizing environment, the RyR is
stimulated, when the oxidizer is pre-treated with a reducing compound (DTT), the
oxidizer loses its stimulating capability. (Jonathan J. Abramson and Guy Salama
1989; Jonathan J. Abramson and Guy Salama 1988; Carnes et al. 2009; Marinov
BS and J.J. Abramson 2005; Xia, Stangler, and J. J Abramson 2000; Anthony C
Zable, Terence G Favero, and Jonathan J Abramson 1997; J.J. Abramson et al.
1983; A. Dulhunty et al. 2000).
Redox active compounds that have shown to modulate the RyR include:
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Heavy Metals (Hg2+, Ag+, Cu2+, Cd2+, Zn2+): Heavy metals bind with high affinity
to protein sulfhydryl groups and activate the ryanodine receptor at low
micromolar concentrations (J. J. Abramson et al. 1983).
Phtalocyanine Dyes: Oxidation by the phthalocyanine dyes (alcian blue (AB),
Cu2+ phthalocyanine tetrasulfonic acid, and Luxol fast blue MBSN) were found to
induce rapid Ca2+ release from actively (Ca2+ ) loaded SR. Pre-reduction of AB
with reducing agents causes loss of stimulating effect indicating that the
compounds are acting via redox sensitive interactions with the RyR. (J. J
Abramson, Cronin, and G. Salama 1988)
Quinones : Naphthoquinone and benzoquinone have been shown to activate
channel activity by oxidation of hyperactive cysteine thiols on the RyR1 and
RyR2 (Feng et al. 1999).
Coumarin maleimide 7-diethylamino-3-(4'-maleimidylphenyl)-4methylcoumarin (CPM) : CPM (1-50 nM) binds to RyR-triadin hyper-reactive
thiols when RyR is in a closed state. Covalent interactions of those thiols with
nanomolar CPM inhibits gating activity. (G. Liu et al. 1994)
1,4-Napthoquione: 1,4-Napthoquione (0.4-40pmol/µM) oxidizes hyperactive
thiols on RyR-triadin and stimulates Ca2+ release from SR vesicles. (G. Liu et al.
1994)
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3
3.1

The Anthocyanidins: Pelargonidin and Delphinidin
Anthocyanidins

Figure 3.1 Basic Structure of Anthocyanidins

Anthocyanidins are one of the six sub-classes of Flavonoids (itself being a subclass of polyphenols). They are compounds of the plant kingdom that have the
general structure of a flavylium cation (2-phenylchromenylium) with a C6C3C6
skeleton and with functionalization occurring at specific locations on the structure
(see Figure 3.1). Functional groups are typically referred to by the number of the
carbon to which it is attached (eg. The C4’ hydroxyl or the 4’-OH). Additionally,
the compound is sometimes characterized by its individual aromatic rings A, B,
and C. Anthocyanidins are salts and usually are identified along with a chloride
counter ion. The counter ion dissociates with the main molecule in solution which
leave a positive charge on the compound. This charge allows anthocyanidins to
absorb light and exhibit intense colors from the orange-reds to the purples. They
provide most of the red to purple colors observed in flowers, leaves, fruits, and
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vegetables. They share a common function in the phyto-kingdom as pigments
used to attract insects for pollination, cellular signaling molecules, anti-fungal
protection, and UV light protection. Specific anthocyanidins are identified by how
the base structure is functionalized with hydrogens, hydroxyl, methoxy, and
sugar groups and the amount and type of substitution contributes greatly to the
color properties of the molecule. There are 23 known anthocyanidins (Øyvind M.
Andersen and Markham 2006). Anthocyanidins have poor solubility in aqueous
solutions but when sugar groups are attached (anthocyanins), they become more
soluble and as such, that is the form that is found most in nature with more than
500 known anthocyanins documented. Although anthocyanins are the more
prevalent, the functional properties of those compounds are due to the aglycon
form (anthocyanidin) and thus most studies focus on that group of compounds
(Estevez and Mosquera 2008; J. B. Harborne, T. J. Mabry, and H. Mabry 1975).
The six anthocyanidins that are considered to be the most important mainly due
to their widespread distribution in nature are pelargonidin, cyanidin, delphinidin,
petunidin, peonidin, and malvidin. Three of these six are considered to be the
principle anthocyanidins due to their minimal substituent groups: delphinidin (Dp),
cyanidin, (Cy),and pelargonidin (Pg). These three all have the same hydroxyl
functionality on the 3, 5, and 7 carbons of the A and C rings. They differ in the
amount of hydroxyl groups on the B-ring. The addition of hydroxyl groups to the
B-ring (R2=OH for pelargonidin, R2=R3=OH for cyanidin, and R1=R2=R3=OH for
delphinidin) causes a bathochromic (red) shift in their absorption spectrum. They
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have absorbance maxima at 530nm, 545nm, and 556nm (respectively) when
prepared in acidified ethanol (Cabrita, Fossen, and Øyvind M. Andersen 2000).
3.2

Anthocyanidin Structural Equilibrium

Anthocyanidins are native to the acidic conditions of the plant cell. Under these
conditions, the anthocyanidins predominately occur in the ‘flavylium cation’ form
as shown in Figure 3.1. Upon placing them in a more alkaline aqueous
environment, they become very unstable and their structure is altered in various
ways depending mainly on the pH but temperature and light can also be effectors.
At very acidic pH, anthocyanidins exist almost exclusively in the flavylium cationic
form (AH+) (see Figure 3.2). When subjected to higher pHs (~5), anthocyanidins
exhibit three distinct chemical reactions involving proton transfers, hydration, and
tautormerizations. Upon a pH jump to ~5, deprotonation immediately occurs on
the hydrogen (or hydrogens) of the flavylium cation with the lowest bond
disassociation enthalpy (BDE) resulting in the quinoidal base form (A) or the
quinoidal base anion form (A-). The flavylium cation (AH+) and the quinoidal base
(A) quickly (<1 sec) come to an equilibrium. On a slower time scale (minutes to
hours), AH+ undergoes hydration to obtain the carbinol pseudobase (B) and/or
the carbinol pseudobase anion (B-). The rate of these reactions are dependent
upon the pH of the environment and on the degree and type of substitutions.
Higher pH generally leads to a slower transformation to the carbinol form
(Brouillard and Delaporte 1977; Brouillard and Dubois 1977). This will depend on
the pKa’s of the substituents of the different anthocyanidins. In addition, the
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quinoidal base transforms to the colorless carbonyl pseudobase (C) form. For
cyanidin (the only kinetic study of a related
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Figure 3.2 The forms of pelargonidin in neutral pH solutions
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anthocyanidin that I found in literature), the half life of this structural
transformation is reported to be 0.5 days (at pH 2.8) (Iacobucci and Sweeny
1983).
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3.3

Pelargonidin

Figure 3.3 Molecular Structure of Pelargonidin

Pelargonidin (Figure 3.4) was first obtained by Willstater and Bolton in 1914 by
the hydrolysis of pelargonin of Pelargonium zonale. It has absorbance maxima in
the 530nm (in EtOH-HCl). Pelargonidin is found in the skin of the red radish,
strawberries, petals of geraniums, and the rose (among others). 22 glycosides of
pelargonidin are known (J.B. Harborne 1967). Pelargonidin has hydroxyl (–OH)
groups at the 3, 5, 7, and (para) 4’ positions. The structural configurations of
pelargonidin are shown in Figure 3.3. When exposed to increasing pH conditions,
compounds with a monohydroxylated B ring (pelargonidin) exhibit a gradual
bathochromic (red) shift up to pH~6, an extensive red shift from pH~6 to pH~7.3,
and a stable λmax from pH7.3 to pH~10-11(Cabrita, Fossen, and Oyvind M
Andersen 2000). These color changes are caused by structural changes as
mentioned in the previous sections. Although the first pKa (pKa1) can be
determined experimentally, subsequent deprotonation pKa’s (pKa2 etc.) are
difficult to determine experimentally due to the simultaneous existence of multiple
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forms of the compound in solution. Thus, to predict the pKa of subsequent
deprotonations of each structural form, quantum mechanical calculations
determining the disassociation energies of each hydrogen must be performed.
The lowest computed BDEs based on the lowest energy structures are
considered the first to deprotonated. In reality, there may be several similarly
valued low energy structures and several hydrogens with similar valued BDEs
which imply a mixture of compounds in solution at all times. When subjected to a
neutral pH environment, pelargonidin rapidly deprotonates and changes from the
flavylium cation from to its quinoidal base form. The first deprotonation is
experimentally been shown to be at pH 5.79. The favored deprotonation site as
calculated numerically is the 5-OH group. The predicted pKa2 for the quinoidal
base form is at pH 7.05 and located at the 4’-OH. At physiological pH (~7.4),
pelargonidin is probably in an anionic quinoidal base form (see Figure 3.2). The
transformation to the anionic quinoidal base is very fast coming with equilibrium
in less than 1 second. A second transformation to the carbinol pseudobase has
slower kinetics with a half life in the 10 minute range (see result section). The
pKa2 for the carbinol form is predicted to be 8.35 and therefore is probably not
anionic at the experimental pH of ~7.1-7.4. The structural change to the chalcone
form is on order of 12-24 hours (data for cyanidin, not pelargonidin). The
predicted pKa2 for the chalcone is 6.73 also at the 4’ position and therefore it is
predicted to be in an anionic form (Borkowski et al. 2005)
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3.4

Delphinidin

Figure 3.4 Molecular Structure of Delphinidin

Delphinidin (Figure 3.4) was first obtained by hydrolysis of delphin (of the
larkspur (Delphinium consolida). It has an absorbance maxima of 556nm (EtOHHCl) and is responsible for rich purple and dark violet colors of berries. It is found
in the skin of eggplant, grapes, and pedals of the hyacinth just to name a few.
(J.B. Harborne 1967)
Compounds with a trihydroxylated B-ring (delphinidin) show a gradual
bathochromic (red) shift up to pH~6, an extensive red shift from pH6 to pH~7.3,
an extensive blue shift from pH7.3 to pH~8.5, and then another red shift at even
higher pH’s. Due to the same (mixture of forms) difficulties as addressed in the
pelargonidin section, the pKa2’s for
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delphinidin are also predicted numerically rather than experimentally.
Delphinidin’s first deprotonation is at pH 5.30 (experimental) and numerical
based deprotonation energies predict it to be the 4’ hydrogen. The predicted pKa2
is at 6.73 at C5. At physiological pH, delphinidin is predicted to rapidly
deprotonate to the quinoidal base anion form with lost hydrogens on 4’ and 5.
The carbinol pseudo base has a predicted pKa2 on C4’ at 7.25 and thus may be
in a mix of its neutral and anionic forms at physiological pH. The predicted pKa2
for the chalcone form is 4.9 also at the 4’ position and therefore it is predicted to
be in a neutral form as well (Borkowski et al. 2005).
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4
4.1

Materials and Methods
Sarcoplasmic Reticulum Vesicles

Sarcoplasmic reticulum was isolated from fast twitch back and hind leg skeletal
muscle extracted from 2-3 kg New Zealand white male rabbits according to the
methods of MacLennan et al (1970) with modifications. Live rabbits were
euthanized, bled, and put on ice. Removed muscle was also put on ice. Fat and
red muscle was trimmed from the fast twitch muscle and discarded. Fast twitch
muscle was cut to approximately 1 inch peices and placed into a cold proteolysis
inhibiting buffer of 120mM NaCl, 10mM imidazole, 100µM DTT, 10µM EGTA, and
100µM leupeptin at pH 7.4. Muscle was then homoginized with a common
household blender (Waring) by a 4X repeating cycle of 15 sec at low speed, 60
sec high speed, and 30 sec of no blending. Homogenate is then centrifuged at
1,600×g for 10 minutes. Supernate is then filtered through four layers of
cheesecloth to remove excess debris and fat. Remaining homogenate is
adjusted to pH 7.4 with imidazole and centrifuged at 10,000×g for 15 minutes to
remove mitochondria. Supernate is retained and centrifuged at 44,000×g for an
additional 70 minutes to collect SR. Supernate is discarded and remaining pellet
is homogenized to approximately 10mg/ml with a buffer of 120mM NaCl, 10mM
imidazole, 100µM DTT, and 50µM EGTA at pH 7.4. The resulting homogenate is
then centrifuged at 7,500×g for 10 min to remove any remaining myosin.
Supernate is retained and centrifuged at 78,000×g to obtain the SR pellet. The
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pellet is then homogenized to approximately 20mg/ml in a buffer of 100 mM KCl
and 20 mM HEPES at pH 7.0. Aliquots of SR are put in cryo-storage tubes and
stored in liquid N2 until needed.
The protein concentration of the SR is then quantified by the method of Kalckar
(1947). The 280nm absorbace of aromatic amino acids tyrosine and tryptophan
combined with the 230nm absorbace of the peptide backbone can be utilized to
determine the total protein concentration (see Equation 4.1). Equation 4.2 is a
correction factor for the possible contamination of nuclecic acids which absorb at
230nm.

Equation 4.1

[ SR ]mg / ml = 1.45 × ( Abs280 ) − 0.74 × ( Abs260 )

Equation 4.2

[ SR]mg / ml = 0.185 × ( Abs230 ) − 0.075 × ( Abs260 )

4.2

Reagents

Ryanodine was purchased from CalBiochem (San Diego, CA), 3[H]-Ryanodine
was purchased from Du Pont – New England Nuclear Co. (Boston, MA),
Pelargonidin chloride (CAS#134-04-3) was purchased from Sigma Aldrich,
Delphinidin chloride (CAS#528-53-0) was purchased from Sigma Aldrich and
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Extrasynthese (France), Antipyrylazo III and A23187 was purchased from Sigma
Aldrich, EtOH was analytical grade 200 proof, anhydrous >99.5%, all water used
has a resistivity of 18 Mohm and was obtained from a Mili-Q System (Millipore
Co), all other reagents (buffers, salts, etc) were of typical laboratory grade unless
noted.

Pelargonidin and delphinidin were prepared at 10mM concentrations in EtOH and
stored at ~-4oC between experiments.
Stock solution was diluted to lower concentration in EtOH in necessitated by the
experiment.

4.3
4.3.1

Methods
Passive Ca2+ Loading of SR Vesicles

Ca2+ was passivily loaded into SR vesicles by incubating undiluted stock SR
(~20mg/ml protein) in 0.5mM to 1mM CaCl2 by the procedure as follows. SR was
removed from LN2 storage and thawed by rubbing between the hands until no
solid SR particles were observed. Multiple storage tubes are thawed and
combined as needed to obtain an amount nessesary for the experiment. An
appropriate amount of 100mM CaCl2 is added to the SR and then vortexed for 35 seconds. The tube is then plunged into LN2 and allowed to freeze solid for ~552

10 seconds. The tube is then thawed again as previously decribed and placed
under crushed ice overnight.
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4.3.2 Ca2+ Efflux Measurements
Ca2+ release from SR vesicles can be monitored and quantified by
spectrophotometric methods utilizing polycationic indicator dyes that change
absorbance with corresponding changes in sample free Ca2+ concentration
(Scarpa, Brinley Jr, and Dubyak 1978). The polycationic indicator dye
Antipyrylazo III (APIII) and a time sharing dual wavelength spectrophotometer
(Chance et al. 1975) (purchased from the University of Pennsylvania) was
utilized for all efflux experiments. The spectrophotometer is a rotating wheel type
with bandpass filters that pass 720nm and 780nm wavelengths from a halogen
source. The passed wavelengths are incident on a photomultiplier tube which is
connected to a multiplexing amplification control module. The control module
conditions the signals by taking the difference between the (Ca2+ responsive)
780nm signal from the (Ca2+ non-responsive) 720nm signal. The difference is
then output as an analog voltage signal, digitized, and recorded on a PC
(AxoScope software, Axon Instruments (now Molecular Devices)). An APIII
buffer containing 100mM KCl, 20mM HEPES, and 200µM APIII at pH 7.4 was
used. SR vesicles were loaded with Ca2+ as previously described. A typical
experiment involves 2 ml of the APIII buffer added to a 4.5ml polystyrene cuvette
with 1cm path length and a magnetic stir bar. Approximately 40µl-50µl (0.4-0.5
mg/ml final protein concentration) of prepared SR is pipetted into the APIII buffer.
The intravascular Ca2+ concentration is now approximately 50-40 fold greater
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than the extravesscular Ca2+. The concentration gradient forces release of Ca2+
through the channel. APIII’s spectrum changes in response to the rising Ca2+
concentration and the resulting signal change is recorded for further analysis. At
the completion of a Ca2+ efflux experiment, the Ca2+ ionophore A23187 is added
(2 µl @ ~1.0 ug/ml) to initiate release of all unreleased intravesscular Ca2+ (to
determine total vesicle loading capability and to assist in data analysis). A known
amount (~5 µM) of CaCl2 can also be added for Ca2+ signal calibration. To assay
for the effect of possible modulators, the modulator is added immediately (<1 sec)
prior to the addition of the SR. The resultant signal is compared to the signal of
the contro. To ensure that the increasing Ca2+ signal is from Ca2+ leaving the
RyR1, the potent inhibitor Ruthenium Red is added immediately prior to the SR.
Ruthenium Red control should block the release of Ca2+ from the SR vessicles.
To quantifiy the results, the data representing the Ca2+ release phase is fit to a
first order exponential rise to max equation (Sigma Plot). Typically, the initial rate
of Ca2+ release is calculated by taking the product of the value of maximum
amount of Ca2+ released (µM) and the rate constant (s-1) which gives the initial
rate of Ca2+ in units of µM/s. The initial rate of Ca2+ release is then compared.
It was verified that Pg and Dp do not significantly alter the Ca2+ response of APIII.
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4.3.3 Ryanodine Binding

4.3.3.1 Ryanodine

Ryanodine (Figure 4.1) is an alkaloid found in the plant Ryania speciosa of South
America. It has a high affinity to the RyR and locks it in a varying degree open
state depending on concentration. Due to it’s specific affinity to the RyR and it’s
use as a label for the first purification of the RyR, the RyR is commonly known as
the ryanodine receptor.

Figure 4.1 Molecular Structure of Ryanodine

The rate of ryanodine binding to the RyR depends on the open probablility of the
RyR. The higher the open probability of the RyR, the greater the rate of Ry
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binding. By using tritiated ryanodine, the amount of rayanodine that binds to the
RyR in a specidfied amount of time can be quantified by a scintillation counter
and be indirectly used to the open state of the RyR. The Beckman LS6500
scintillation counter is utilized for this purpose.

4.3.3.2 Binding Assays
SR (0.5 mg/ml) is combined with a standard ryanodine buffer of 250mM KCl, 15
mM NaCl, and 20 mM HEPES at pH 7.1. [3H]-ryanodine is added to obtain a final
[3H]-ryanodine concentration of 2 nM. Mixtures are kept on ice. Solutions of
pelargonidin and delphinidin were taken from stock and diluted to obtain a
useable stock concentration if required. [3H]-ryanodine, SR, and pelargonidin or
delphinidin are mixed to obtain desired final concentrations. Mixtures are placed
in a 37oC water bath for the period of time needed for the experiment. At the end
of the time period, the ryanodine binding reaction is then quenched by rapid
filtration through Whatman GF/B glass fiber filter sheets on a Brandel cell
harvester. Sample tubes are rinsed 2x using a standard rinse buffer similar to
standard ryanodine buffer. Filtered samples are placed in scintillation vials with
5ml scintillation fluid, placed on a shaker overnight, and then counted on a
Beckman L-6500 scintillation counter. RyR non-specific binding is measured by
addition of a 200X excess of non-labeled ryanodine to a control sample. Total
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activity is measured by counting an unfiltered sample (2 nM [3H]-ryanodine).
Binding quantification is determined by the following equations:

B pmol / mg =
Equation 4.3

SA =
Where

dpm sample − dpm NS
1
×
[ SRsample ] × vol sample
SA

dpmTA
[ Ry total ] × vol ryanodine
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5
5.1

Results
Spectrometric Analysis of Ca2+ Efflux from SR Vesicles

5.1.1 Pelargonidin Inhibits / Delphinidin Stimulates - Ca2+ Efflux from SR
Vesicles
This experiment was performed as noted in the methods section. Pg and Dp
were added to the APIII buffer immediately (within 1 sec) prior to the addition of
the Ca2+ loaded SR vesicles. At the concentrations tested (25µM and 50µM), the
Pg and Dp stock solutions added 0.25% and 0.5% EtOH (vol) respectively to the
APIII buffer. To minimize any effect that the EtOH may have on the RyR and
Ca2+ efflux, 0.5% EtOH was also added to the control trials. Ruthenium Red
(5µm) was utilized to ensure Ca2+ efflux was occurring through the RyR and not
through other means such as membrane diffusion. Results show (Figure 5.1) that
25µM and 50µM Pg both inhibit the release rate of Ca2+ from the RyR in a dose
dependent manner and that 25µM and 50µM Dp both stimulate the release rate
of Ca2+ from the RyR in a dose dependent manner with respect to the control. It
is worth noting that 50µM Pg exhibits a [Ca2+]max that is less than half of the
[Ca2+]max for all other traces. This may be due the existence of a high affinity Pg
binding site that is exposed at higher levels of inhibition (higher Pg
concentrations). Once the site is revealed, the abundant levels of Pg can bind
strongly and effectively close the channel to Ca2+ flux. This is highly speculative
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however and similar results were not duplicated in other concentration dependent
experiments (see Figure 5.3).
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Figure 5.1 Dp stimulates Ca
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Traces of Ca efflux from Ca loaded skeletal SR vesicles. Stock SR vesicles (~20 mg/ml
protein) incubated with 1 mM CaCl2 overnight (~12-16 hours) on ice. Experiments
2+
performed in 200µM APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca release is stimulated by
2+
dilution of SR into APIII buffer (~40:1). Final protein concentration = 0.3-0.5 mg/ml. Ca
release is stimulated by both 25µM (▲) and 50µM (△
△) Dp and inhibited by both 25µM (▼
▼)
and 50µM (▽
▽) Pg with respect to the control (■
■) (0.5% EtOH). 5µM (●
●) Ruthenium Red added
to verify release is through RyR1. Both Pg and Dp were added to APIII buffer immediately
prior to addition of SR. Error bars represent standard deviation for n=4 for control and n=3
for all other data.
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Efflux from SR is Modulated by Pg and Dp.

2+

Initial rate of Ca release is stimulated by both 25µM and 50µM Dp and inhibited by both
25µM and 50µM Pg with respect to the control (0.5% EtOH). Data from figure 5.1 were fit to
first order rise to max exponential functions and results used to calculate the initial rate.
2+
Experiments performed in 200µM APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca release is
stimulated by dilution of SR into APIII buffer (~40:1). Final protein concentration = 0.3-0.5
mg/ml. Both Pg and Dp were added to APIII buffer immediately prior to addition of SR.
Error bars represent standard deviation for n=4 for control and n=3 for all other data.
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5.1.2 Pelargonidin Modulates the Initial Rate of Release in a Biphasic
Manner
The initial rate of Ca2+ efflux from the SR is stimulated by 1µM and 5µM
concentrations of Pg. Concentrations from 40µM to 160µM showed increased
inhibition of Ca2+ efflux. A traditional explanation for this type of biphasic behavior
is the interaction with more than one class of binding sites on the RyR. At low
micromolar concentration of Pg, binding to high affinity at binding sites results in
channel activation, while at higher concentrations, binding to a lower affinity site
results in inhibition of the channel. This may be the case here but Pg also can
show prooxidant behavior at low concentrations and antioxidant behavior at
higher concentrations (see chapter 1 and 3) and this characteristic may also
contribute to the biphasic character shown here. The data in this section doesn’t
support the decreased [Ca2+]max at higher Pg concentrations (Figure 5.1). The
reason for this inconsistency is not known and warrants replicate trials to confirm
results. The complex effect that Pg has on the RyR coupled with the lack of more
detailed concentration dependence data would render further quantitative
analysis as questionable and thus kinetic analysis will not be presented.
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Figure 5.3 Pg modulates the initial rate of Ca

efflux from skeletal SR in a biphasic manner.

2+

Initial rate of Ca release is stimulated by 1 µM and 5 µM Pg and inhibited by Pg
concentrations greater than 10 µM with respect to the control (0.5% EtOH). Experiments
2+
performed in 200µM APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca release is stimulated by
dilution of SR into APIII buffer (~40:1). Stock SR vesicles (~20 mg/ml protein) incubated
with 1 mM CaCl2 overnight (~12-16 hours) on ice. Pg was added to APIII buffer immediately
prior to addition of SR. Final protein concentration = 0.3-0.5 mg/ml. Results shown are for
one trial.
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5.1.3 Delphinidin stimulates Ca2+ release from the RyR of the SR
Delphinidin stimulates the initial rate of Ca2+ efflux from the RyR for all
concentrations tested (Figure 5.3). EC50 = 9.3µM +/- 1.3µM (initial rate data
(Table 5.4) fit to a four parameter logistic function (Figure 5.5)). The data is the
result of only one trial at each concentration and therefore should be repeated to
obtain statistical confidence. The data value at 80µM is approximately 30% less,
and not in agreement with, the surrounding data point at 40µM and 160µM. The
reason for this is unknown but I suspect that this is an artifact of an experimental
error and warrants additional experimental confirmation.
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Figure 5.4 Dp stimulates initial rate of Ca

release from skeletal SR.

2+

Initial rate of Ca release is stimulated by Dp in a concentration dependent manner with
respect to the control (~0.5% EtOH). Experiments performed in 200µM APIII, 100mM KCl,
2+
20mM HEPES, pH 7.4. Ca release is stimulated by dilution of SR into APIII buffer (~40:1).
Stock SR vesicles (~20 mg/ml protein) incubated with 1 mM CaCl2 overnight (~12-16 hours)
on ice. Dp was added to APIII buffer immediately prior to addition of SR. Final protein
concentration = 0.3-0.5 mg/ml. Results shown are for one trial.
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Figure 5.5 Dp - Dose Response Curve.
Dose-response data from figure 5.4 fit to a four parameter log function and the half
maximal effective concentration (EC50) was obtained (Sigma Plot). EC50=9.3µM +/-1.3µM.
Data point at 80µM (open circle) omitted from curve fit. Experiments performed in 200µM
2+
APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca release is stimulated by dilution of SR into
APIII buffer (~40:1). Stock SR vesicles (~20 mg/ml protein) incubated with 1 mM CaCl2
overnight (~12-16 hours) on ice. Dp was added to APIII buffer immediately prior to addition
of SR. Final protein concentration = 0.3-0.5 mg/ml. Results shown are for one trial.
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5.1.4 Pelargonidin and Delphinidin; Different Forms, Different Effects
Both pelargonidin and delphinidin undergo structural changes when exposed to
weakly acidic to alkaline solutions (see chapters 1 and 3). The Ca2+ efflux assay
has the benefit of being able to more tightly control the time in which Pg and Dp
are exposed to the environmental conditions of the assay. In this experiment,
stock Pg and Dp were diluted 1:1 in 20mM HEPES at pH7.4 and allowed to set
for times periods of 1 hr, 2 hrs, and 4 hrs (all +/- 15 minutes). The samples were
then used to determine their effect on Ca2+ efflux. Significant structural changes
in Pg and Dp take place in this time period at pH7.4. Results show (Figure 5.6)
that Dp loses its ability to stimulate the RyR by a factor of almost 2 after a 1hr
exposure to pH7.4. An additional decrease in effectiveness is also seen after
2hrs and 4hrs of dilution time with the final effect being only a slight stimulation of
channel activity as compared to the control. Pg loses its inhibitory effect
completely after 1 hour of exposure to pH7.4 and its effects on the RyR seem to
change from inhibitory effect to a slight stimulating effect after 1hr of dilution..
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Figure 5.6 Time of exposure to pH7.4 alters the modulation effects that Dp and Pg have on
2+
the initial rate of Ca release on skeletal SR.
The inhibition effects of Pg (25µM) are lost after it is exposed to pH 7.4 for 1 hour and
slight stimulatory effects are exhibited at longer exposures (2 and 4 hours). Dp (25µM)
loses approximately half of its stimulatory effect after 1 hour and continues to lose its
stimulatory action at longer exposures (2 and 4 hrs). Experiments performed in 200µM
2+
APIII, 100mM KCl, 20mM HEPES, pH 7.4. Ca release is stimulated by dilution of SR into
APIII buffer (~40:1). Stock SR vesicles (~20 mg/ml protein) incubated with 1 mM CaCl2
overnight (~12-16 hours) on ice. Dp was added to APIII buffer immediately prior to addition
of SR. Final protein concentration = 0.3-0.5 mg/ml. Error bars represent standard deviation
for n=3 trial for the control, n=1 for 4hr Dp trial, and n=2 for all other trials.
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5.2

Ryanodine Equilibrium Binding

5.2.1 Pelargonidin and Delphinidin Modulate [3H]-Ryanodine Binding
The equilibrium binding assay is carried out over for 3 hours to ensure chemical
equilibrium of the binding of ryanodine to the RyR. Qualitatively, Figure 5.9
shows that both Dp and Pg stimulate equilibrium binding with respect to the
control but with Dp stimulating the channel more effectively than Pg. Quantitative
analysis and determination of the EC50 would require an assay that includes a
broader range of concentrations (greater than 25µM) and thus was not performed.
Interestingly, in this assay, Pg exhibits a stimulatory effect. The reason for this is
unknown but it can be hypothesized that the change is related to the structural
and function changes that Pg undergoes during the 3 hour incubation at neutral
pH conditions required for this assay. This stimulatory effect by Dp is consistent
with the stimulatory effect seen in the Ca2+ efflux studies.
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Figure 5.7 Pg and Dp stimulate ryanodine equilibrium binding.
Both Dp (□) and Pg (◯
◯) stimulate ryanodine equilibrium binding in a concentration
dependent manner with respect to the control. Samples contain 4nM Ryanodine, 0.5 mg/ml
2+
SR vesicles, 50µM Ca in pH 7.1 binding buffer. SR vesicles and ryanodine solutions kept
on ice prior to dispensing into incubation tubes. Addition sequence: SR (1 mg/ml) in Ry
3
buffer, [H]Ry in Ry buffer, and Pg or Dp. After addition of Pg/Dp samples are put in 37ºC
bath, removed after 3hrs, and the reaction is quenched by rapid filtration.
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5.3

Short Duration Ryanodine Binding

Short duration Ry binding measures Ry binding over a time period of generally
less than 20 minutes but other time periods can also be used. Figure 5.8 shows
the results of this assay. Delphinidin clearly causes an increase in the initial rate
of ryanodine binding with increasing concentration. Attempts made to fit the data
to dose response curves did not converge. The lack of strong inhibition in this
experiment by Pg can be partially attributed to the low level of binding by the
control. In addition, changes in Pg’s structure and the resulting change in its
effect on the RyR may also be of importance. In an attempt to enhance the
background level of binding and better reveal the effects of Pg on ryanodine
binding during initial exposure to pH7.1 buffers, assays were conducted with both
5mM and 10mM caffeine, a known RyR stimulator, added to the experiment.
Figure 5.9 shows that caffeine stimulated binding is strongly inhibited by Pg.
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Figure 5.8 Pelargonidin inhibits caffeine stimulated ryanodine binding
Pelargonidin inhibits 5mM (◯
◯) and 10mM (□) caffeine stimulated ryanodine binding in a
3

concentration dependent manner with respect to the control. Samples contain 4nM [H]2+
Ryanodine, 0.5 mg/ml SR vesicles, 50µM Ca in pH 7.1 binding buffer. SR vesicles and
ryanodine solutions kept on ice prior to dispensing into incubation tubes. Addition
3
sequence: SR (1 mg/ml) in Ry buffer, [H]-Ry in Ry buffer, and Pg. After addition of Pg,
samples are put in 37ºC bath for 5min and then removed and the reaction quenched by
rapid filtration.
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Figure 5.9 Comparison of [H]-ryanodine binding effects of Pg at short and long exposures
to a pH 7.1 aqueous buffer.

▼

▽

3

When Pg’s exposure to a pH 7.1 buffer is limited to 5 ( ) or 6 ( ) minutes, Pg inhibits [H]Ryanodine binding to the skeletal RyR. When the structural changes are allowed to
3
proceed for 3 hours (▲), Pg stimulates [H]-ryanodine binding to the skeletal RyR.
3
2+
Samples contain 4nM [H]-ryanodine, 0.5 mg/ml SR vesicles, 50µM Ca in pH 7.1 binding
buffer. SR vesicles and ryanodine solutions kept on ice prior to dispensing into incubation
3
tubes. Addition sequence: SR (1 mg/ml) in Ry buffer, [H]-Ry in Ry buffer, and Pg. After
addition of Pg, samples are put in 37ºC bath for 5min and then removed and the reaction
quenched by rapid filtration.
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5.4

Spectrophotometric Characteristics of Pelargonidin and Delphinidin

5.4.1 Absorbance Spectrum of Pg and Dp
The absorbance spectrum exhibited by Pg and Dp is very dependent upon the
pH of the solution as well as the time that Pg and Dp have been exposed to that
pH. Figures 5.11 and 5.12 show the spectrums of Pg and Dp respectively at
various pH’s. The spectrum was taken as quickly as possible (~3sec) after the
dilution of 40 µM (final concentration) Pg or Dp from its EtOH stock solution into
1mM Tris buffer at various pH’s. Results show the characteristic bathochromatic
shifts of their spectrums that are expected at increasing pH (Cabrita, Fossen, and
Øyvind M. Andersen 2000).
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Figure 5.10 pH dependent absorbance spectrum of pelargonidin
40uM Pg pipetted from 10mM stock in EtOH to 1mM TRIS (pH’d with HCl and/or KOH) and
spectrum collected within 5 seconds. Solid line: pH=6.5, long dashes: pH=7.0, short
dashes: pH=7.5, dotted trace: pH=8.0
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Figure 5.11 pH dependent absorbance spectrum of delphinidin
40uM Dp pipetted from 10mM stock in EtOH to 1mM TRIS (pH’d with HCl and/or KOH) and
spectrum collected within 5 seconds. Solid line: pH=6.5, long dashes: pH=7.0, short
dashes: pH=7.5, dotted trace: pH=8.0
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5.4.2 pH Dependent Transformation Kinetics of Pg and Dp
Upon dilution into a neutral pH solution, Pg and Dp rapidly deprotonate into their
respective quinoidal base forms. This transformation occurs in a time frame
faster than that required to add, mix, and collect the initial spectrum and thus
cannot be followed using the technique described here. The subsequent slower
transformation from the quinoidal base form to the carbinol pseudobase form is
shown in Figure 5.13. The time required to add, mix, and collect the initial
spectrum is on the order of a few seconds and therefore this measurement will
only provide an estimate of the actual kinetics. However, this data is in
agreement with the literature in that the transformation kinetics of these
compounds increase with increasing acidity. In addition, the relative
concentration of the quinoidal form with respect to the (colorless) carbinol form is
dependent on pH. Unfortunately, the equilibrium constants for these compounds
are not known and concentrations of the different forms cannot be determined.
The kinetics of Pg and Dp are similar and when fitted to a first order decay
equation, the t1/2 is on the order of 100 seconds at pH7.0. The kinetics
significantly slow down at pH 7.5 and it is therefore not possible to estimate the
t1/2 at this pH.
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Figure 5.12 pH dependent transformation kinetics of Pg and Dp
Kinetics of the decrease in absorbance of the quinoidal form of Pg and Dp over 300
seconds. Traces for pH 6.5 (t1/2~50 sec), 7.0 (t1/2~50 sec), 7.5 (t1/2~not enough data) and 8.0
(t1/2~not enough data) are shown. Black traces are Dp and Lt.Grey traces are Pg. Solid line:
pH=6.5, long dashes: pH=7.0, short dashes: pH=7.5, dotted trace: pH=8.0.
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6

Discussion

The complex nature of pelargonidin and delphinidin with respect to their pH
dependent molecular structures and properties makes it difficult to quantitatively
assess the two compounds with regards to RyR modulation. However, calcium
efflux experiments do allow for assessment of the effects of pelargonidin and
delphinidin within seconds of exposure when concentrations of specific forms are
known to dominate. Upon exposure to physiological pH solutions, pelargonidin
and delphinidin rapidly (~1 second) deprotonate to their corresponding quinoidal
base and quinoidal base anion forms whereas the subsequent transformation to
the carbinol pseudobase is on the order of minutes at pH 7 and significantly
longer in more alkaline solutions. The Ca2+ efflux assays utilized in this thesis can
probe the modulatory effect that a compound has on the channel in time periods
as short as several seconds and therefore can effectively assay pelargonidin and
delphinidin in their quinoidal forms. Additionally, the transformation of
pelargonidin and delphinidin to the chalcone form is likely on the order of twelve
to twenty four hours (based on similar compounds found in literature) and
therefore there is a time period after the transformation into the carbinol
pseudobase that the Ca2+ efflux assay can probe the effects of that form as well.
Delphinidin is predicted to be in a quinoidal base anion form almost immediately
after exposure to a pH 7.4 solution. Hydroxyl groups at positions 4’ and 5 are the
predicted deprotonation sites. Calcium efflux results show that delphinidin is a
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good RyR1 stimulator with an EC50 of 9.3µM. However this result is obtained
within the first fraction of a minute after Dp is exposed to the pH 7.4 of the Ca2+
efflux buffer. When Dp is allowed to transform into the carbinol pseudobase form,
a majority of its stimulatory effects are essentially lost. This implies that the
quinoidal base form is primarily responsible for Dp’s stimulatory effects on the
RyR. This also implies that the carbinol pseudobase form doesn’t have a strong
modulatory effect. Although there is still a small stimulatory effect seen even after
the carbinol is formed, this may be due to the fact that there is still an equilibrium
concentration (not known) of quinoidal base in solution or that stimulatory
autoxidation products of Dp are present in the solution (both superoxide and
hydrogen peroxide have been shown to stimulate the RyR1 (T. G Favero, A. C
Zable, and J. J Abramson 1995; Kawakami and Okabe 1998)). [3H]-ryanodine
binding experiments at both short [3H]-ryanodine incubation times (~ 6 minutes
(data not shown)) and long incubation times (~ 3 hours) also show stimulatory
effects. Again, the stimulatory effects for longer time periods are suspect in part
due to the autoxidation capabilities of Dp.
With pelargonidin, the modulating mechanism is more complex. Pelargonidin is
also predicted to be in a quinoidal base anion form immediately after exposure to
a pH 7.4 solution. Hydroxyl groups at positions 5 and 4’ are the predicted
deprotonation sites but the 5 and 3 are close in energy and probably co-exists in
significant concentrations. Calcium efflux results imply that the quinoidal form of
pelargonidin is a RyR1 inhibitor. In contrast, the carbinol pseudobase does not
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seem to be effective at inhibiting the RyR. There is even a slight hint of some
channel stimulatory effects. [3H]-ryanodine binding experiments performed with
short [3H]-ryanodine incubation times (~ 5 minutes) also show activation of
receptor binding. As is the case with delphinidin, the structural form 3 hours after
exposure to neutral pH conditions is also the carbinol pseudobase although, for
pelargonidin, the predicted (lowest) pKa of that form is 8.32 (3-OH) and
therefore it probably exists with a neutral charge. Longer [3H]-ryanodine
incubation times (~ 3 hours) exhibited significant channel stimulatory effects on
the RyR. Unlike Dp, Pg is not known to autoxidize and therefore the generation
of oxidation products doesn’t seem to be a probable explanation for the
stimulatory action.
For the quinoidal base forms, both compounds are predicted to be planar and
both compounds are charged with the deprotonation sites on the 5 and 4’
oxygens. However, the relative order of the acidities of the hydrogens of those
groups are reversed. Dp loses its first hydrogen at O4’ (experimental pKa1~5.30)
and its second hydrogen at O5 (predicted pKa2~6.30) whereas pelargonidin loses
its first hydrogen at O5 (experimental pKa1~5.79) and its second hydrogen at O4’
(predicted pKa2~7.05). The second predicted deprotonation of pelargonidin is
also close to the pH of the assays performed in this thesis (pH7.1 for ryanodine
binding and pH7.4 for Ca2+ efflux) which means that pelargonidin will exist as
more of a mixture of both the neutral quinoidal base and the anionic quinoidal
base forms. This may impart more of a hydrogen donor characteristic to
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pelargonidin relative to delphinidin. The relative order of the deprotonation sites
may also impart differing molecular polarization characteristics to Pg. How this
may affect the RyR is unknown due to the lack of knowledge regarding the Pg
(and Dp) binding site(s). Structural information regarding the carbinol
pseudobase forms of these compounds was not found in literature however the
predicted pKa2 of the carbinol pseudobase forms of pelargonidin and delphinidin
are 8.35 (at the 3-OH) and 7.25 (at the 4’ OH) respectively. Thus, when the
carbinol pseudobase structures are formed (in neutral pH conditions),
pelargonidin carries mostly a neutral charge whereas Dp is in a mixture of neutral
and anionic forms (Borkowski et al. 2005).

In conclusion, the distinct and powerful effects that the anthocyanidin compounds
studied in this thesis potentially have on skeletal ryanodine receptor mediated
Ca2+ homeostasis is further proof of the necessity to fully understand the
complete effects of nutraceuticals before dietary intake recommendations can be
made.
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